The prevalence of paramagnetic rim lesions in multiple sclerosis: A systematic review and meta-analysis

Koy Chong Ng Kee Kwong1, Daisy Mollison1, Rozanna Meijboom1

  • 1Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom.

Plos One
|September 8, 2021
PubMed
Abstract

Insights

Paramagnetic rim lesions are common in multiple sclerosis (MS) patients, but their assessment varies. Standardized guidelines are needed to improve diagnostic and prognostic accuracy for these potential MS biomarkers.

Area of Science:

  • Neuroimaging
  • Biomarkers
  • Multiple Sclerosis Research

Background:

  • Paramagnetic rim lesions (PRLs) on susceptibility-based MRI are emerging as potential biomarkers in multiple sclerosis (MS).
  • Existing literature on the prevalence of PRLs requires systematic evaluation to understand their diagnostic and prognostic significance.

Purpose of the Study:

  • To systematically review and meta-analyze the literature on paramagnetic rim lesions and chronic active lesions in MS.
  • To estimate the pooled prevalence of these lesions at both lesion-level and patient-level.
  • To explore heterogeneity and identify factors influencing lesion prevalence.

Main Methods:

  • Comprehensive database searching (PubMed, Embase) and handsearching were performed.
  • Meta-analysis using the DerSimonian-Laird random-effects model to pool prevalence data.
  • Subgroup analysis and meta-regression to investigate sources of heterogeneity.

Main Results:

  • 29 studies with 1230 patients were included.
  • Pooled prevalence: 9.8% lesion-level and 40.6% patient-level for rim lesions; 12.0% lesion-level and 64.8% patient-level for chronic active lesions.
  • Significant heterogeneity observed; patient-level prevalence differed between 3T and 7T MRI (p=0.0312). Age and disease duration influenced lesion-level prevalence (p<0.0018).

Conclusions:

  • Paramagnetic rim lesions are present in a substantial proportion of MS patients, though assessment methods vary significantly.
  • Standardized guidelines for assessing paramagnetic rim lesions are crucial for consistent research and clinical application.
  • Further research is needed to fully elucidate the clinical relevance of these lesions as MS biomarkers.